Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06519279

Freezing of Gait - Clinical Outcomes Assessment

An International Multimodal Protocol for Assessing Freezing of Gait in Individuals Living with Parkinson's Disease

Status
Recruiting
Phase
Study type
Observational
Enrollment
20 (estimated)
Sponsor
Tel-Aviv Sourasky Medical Center · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To develop a reliable and accurate clinician-reported outcome (ClinRO) measure (against a new and precise definition) and patient reported outcome (PRO) for use by clinicians and researchers to quantify the severity of Freezing of Gait (FOG).

Conditions

Interventions

TypeNameDescription
DEVICEOpalsFive Oplas sensors were strategically placed on participants: one on each shin, one on each foot, and one on the lower back.
DEVICEAxivityAt the end of the first session, participants with FOG, will be fitted with an Axivity monitor. This is wearable sensor that will be attached to the participant's lower back (lumbar vertebrae 4-5) with hypoallergic medical tape by the researcher, and will be worn continuously for seven days. The Axivity monitor is a small (23 x 32.5 x 8.9 mm) and lightweight (11g) device that measures mobility via a tri-axial accelerometer and gyroscope and stores this data onboard, no GPS or other localization options are possible with this monitor. Participants will be given following guidelines concerning the use: The sensor is to be worn continuously during the seven-day period, i.e. also while sleeping and showering. The sensor is waterproof and can be worn during showering.

Timeline

Start date
2024-10-01
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2024-07-25
Last updated
2025-01-28

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT06519279. Inclusion in this directory is not an endorsement.